RiverPark Advisors’s Insmed INSM Stock Holding History

RiverPark Advisors’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$71.8K	Buy	439 +107	+32%	+$16.5K	0.03%	124
2025 Q4	$57.8K	Buy	332 +71	+27%	+$13K	0.02%	138
2025 Q3	$37.6K	Buy	+261	New	+$32K	0.02%	130

Other funds holding INSM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

RiverPark Advisors's INSM Position: Q1 2026 in Review

RiverPark Advisors increased its Insmed (INSM) stake by 32% in Q1 2026, buying an estimated $16.5K and bringing the position to 439 shares worth $71.8K. The position accounts for 0.03% of the portfolio, ranked #124.

RiverPark Advisors first reported a position in INSM in Q3 2025 and has held it in 3 quarters since. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

RiverPark Advisors held 439 shares of Insmed worth $71.8K as of Q1 2026.
RiverPark Advisors bought 107 Insmed shares in Q1 2026, an estimated $16.5K.
Insmed made up 0.03% of RiverPark Advisors's portfolio in Q1 2026, its #124 holding.
RiverPark Advisors first reported a position in Insmed in Q3 2025 and has held it in 3 quarters since.
669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on RiverPark Advisors's 13F filing for Q1 2026, filed 14 May 2026.